Intellia 治療公司
DE ˙ DB ˙ US45826J1051
€13.00 ↑1.80 (16.07%)
2026-06-04
分享價格
SecurityDE:38I / Intellia Therapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership103,100 shares
Latest Disclosed Value $ 926,869
Alliancebernstein L.p. ownership in 38I / Intellia Therapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 103,100 shares of Intellia Therapeutics, Inc. (DE:38I) valued at $1,139,255 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 103,100 shares of Intellia Therapeutics, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,340,300 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 103,100 0 0.00 927 0.00 0.0003
2026-02-17 2025-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 103,100 0 0.00 927 -47.98 0.0003
2025-11-14 2025-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 103,100 0 0.00 1,781 84.07 0.0006
2025-08-14 2025-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 103,100 0 0.00 967 31.92 0.0003
2025-05-15 2025-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 103,100 -162,218 -61.14 733 -76.30 0.0003
2025-02-12 2024-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 265,318 -1,928,469 -87.91 3,094 -93.14 0.0010
2024-11-14 2024-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 2,193,787 410,903 23.05 45,082 12.99 0.0151
2024-08-14 2024-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,782,884 211,360 13.45 39,901 -7.71 0.0139
2024-05-14 2024-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,571,524 -92,218 -5.54 43,233 -14.78 0.0153
2024-02-14 2023-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,663,742 116,630 7.54 50,727 3.70 0.0195
2023-11-14 2023-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,547,112 -175,665 -10.20 48,920 -30.37 0.0208
2023-08-15 2023-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,722,777 -42,151 -2.39 70,255 6.80 0.0287
2023-05-15 2023-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,764,928 75,206 4.45 65,779 11.58 0.0282
2023-02-15 2022-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,689,722 267,521 18.81 58,954 -25.92 0.0265
2022-11-15 2022-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,422,201 -282,450 -16.57 79,586 -9.80 0.0385
2022-08-15 2022-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,704,651 -43,030 -2.46 88,233 -30.53 0.0403
2022-05-13 2022-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,747,681 285,021 19.49 127,004 -26.56 0.0490
2022-02-14 2021-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,462,660 225,756 18.25 172,945 4.23 0.0611
2021-11-10 2021-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,236,904 27,436 2.27 165,931 -15.27 0.0655
2021-07-30 2021-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 1,209,468 -548,344 -31.19 195,825 38.81 0.0786
2021-05-06 2021-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 1,757,812 1,695,712 2,730.62 141,073 4,076.23 0.0619
2021-02-08 2020-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 62,100 500 0.81 3,378 175.76 0.0016
2020-11-12 2020-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 61,600 -1,300 -2.07 1,225 -7.34 0.0007
2020-08-13 2020-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 62,900 9,300 17.35 1,322 101.52 0.0008
2020-05-14 2020-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 53,600 0 0.00 656 -16.54 0.0005
2020-02-18 2019-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 53,600 0 0.00 786 9.78 0.0004
2019-11-14 2019-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 53,600 0 0.00 716 -18.36 0.0004
2019-08-14 2019-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 53,600 0 0.00 877 -4.15 0.0005
2019-05-14 2019-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 53,600 -5,200 -8.84 915 13.95 0.0006
2019-02-13 2018-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 58,800 0 0.00 803 -52.29 0.0006
2018-11-08 2018-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 58,800 0 0.00 1,683 4.60 0.0011
2018-08-13 2018-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 58,800 35,400 151.28 1,609 225.71 0.0011
2018-05-14 2018-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 23,400 -4,900 -17.31 494 -9.19 0.0004
2018-02-13 2017-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 28,300 1,200 4.43 544 -19.17 0.0004
2017-11-13 2017-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 27,100 -3,300 -10.86 673 38.48 0.0005
2017-08-10 2017-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 30,400 4,600 17.83 486 33.52 0.0004
2017-05-11 2017-03-31 13F INTELLIA THERAPEUTICS COM 45826J105 25,800 0 0.00 364 7.69 0.0003
2017-02-13 2016-12-31 13F INTELLIA THERAPEUTICS COM 45826J105 25,800 2,900 12.66 338 -13.33 0.0003
2016-11-10 2016-09-30 13F INTELLIA THERAPEUTICS COM 45826J105 22,900 2,600 12.81 390 -9.93 0.0003
2016-08-11 2016-06-30 13F INTELLIA THERAPEUTICS COM 45826J105 20,300 20,300 433 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.